In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OTC labeling "feedback" meeting with NDMA scheduled for May 8.

This article was originally published in The Tan Sheet

Executive Summary

OTC LABELING REG COMMENT PERIOD EXTENSION UNLIKELY, FDA Office of Drug Evaluation V Director Michael Weintraub, MD, said at a May 1 Nonprescription Drug Manufacturers Association industry briefing in New York City. NDMA recently requested a 90-day extension to the June 27 deadline; the industry group said it would use the extra time to analyze data from a member survey on the proposed reg and develop model labels. Separately, the Cosmetic, Fragrance & Toiletry Association requested a 120-day extension; CTFA wants to submit comments after its September board meeting ("The Tan Sheet" April 28, p. 15). FDA's labeling proposal was published for comment in the Feb. 27 Federal Register ("The Tan Sheet" March 3, pp. 3-9).





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts